Structure-activity relationship of S-benzylisothiourea derivatives to induce spherical cells in Escherichia coli

被引:35
|
作者
Iwai, N
Ebata, T
Nagura, H
Kitazume, T
Nagai, K
Wachi, M
机构
[1] Tokyo Inst Technol, Dept Bioengn, Midori Ku, Yokohama, Kanagawa 2268501, Japan
[2] Tokyo Inst Technol, Frontier Collaborat Res Ctr, Midori Ku, Yokohama, Kanagawa 2268501, Japan
[3] Chubu Univ, Dept Biol Chem, Kasugai, Aichi 4878501, Japan
基金
日本学术振兴会;
关键词
benzylisothiourea; chromosome partitioning; rod-shape determination; spherical cell;
D O I
10.1271/bbb.68.2265
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We have previously reported that a novel S-benzylisothiourea derivative, S-(3,4-dichlorobenzyl)isothiourca, tentatively named A22, induced spherical cells in Escherichia coli. To elucidate the structural element(s) required for inducing these spherical cells, the biological activity of S-benzylisothiourea derivatives and related compounds toward E. coli cells was investigated. S-(4Chlorobenzyl)isothiourea revealed spherical cell-inducing activity, although being slightly less potent than A22, and S-benzylisothiourea itself showed much less activity. S-Cyclohexylmethylisothiourea did not show antibacterial. activity and had little effect on the cell shape. S-Heptylisothiourea showed antibacterial activity and induced elongated cells rather than spherical cells. Benzylisothiocyanate inhibited cell growth but did not induce spherical cells. S-Ethylisothiourea, benzylthiocyanate, benzylisocyanate, and N-phenylthiourea did not show any activity under the present experimental conditions. These results indicate that the S-benzylisothiourea structure was necessary and sufficient for inducing spherical cells and that 3- and/or 4-chlorosubstitution of the S-benzyl group enhanced this activity.
引用
收藏
页码:2265 / 2269
页数:5
相关论文
共 50 条
  • [21] Structure-Activity Relationship of Benzofuran Derivatives with Potential Anticancer Activity
    Farhat, Joviana
    Alzyoud, Lara
    Alwahsh, Mohammad
    Al-Omari, Basem
    CANCERS, 2022, 14 (09)
  • [22] STRUCTURE-ACTIVITY RELATIONSHIP STUDIES OF PHENCYCLIDINE DERIVATIVES IN RATS
    CONE, EJ
    MCQUINN, RL
    SHANNON, HE
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1984, 228 (01): : 147 - 153
  • [23] STRUCTURE-ACTIVITY RELATIONSHIP IN TASTE EFFECT OF RIBONUCLEOTIDE DERIVATIVES
    MIZUTA, E
    NISHIKAWA, M
    SUGIBAYASHI, H
    SUZUKI, N
    TODA, J
    IMAI, K
    CHEMICAL & PHARMACEUTICAL BULLETIN, 1972, 20 (06) : 1114 - +
  • [24] The antibacterial structure-activity relationship for common chitosan derivatives
    Rathinam, Sankar
    Solodova, Svetlana
    Kristjansdottir, Ingibjorg
    Hjalmarsdottir, Martha A.
    Masson, Mar
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2020, 165 (165) : 1686 - 1693
  • [25] EPILEPTOGENIC ACTION OF PENICILLIN DERIVATIVES - STRUCTURE-ACTIVITY RELATIONSHIP
    ESPLIN, B
    THEORET, Y
    SEWARD, E
    CAPEK, R
    NEUROPHARMACOLOGY, 1985, 24 (06) : 571 - 575
  • [26] The Study of the "Structure-Activity" Relationship For a Cinnamic Acid Derivatives
    Mashentseva, Anastassiya A.
    Seitembetov, Talgat S.
    JOURNAL OF SIBERIAN FEDERAL UNIVERSITY-CHEMISTRY, 2010, 3 (02): : 183 - 192
  • [27] STRUCTURE-ACTIVITY RELATIONSHIP AMONG POLYHYDRO DERIVATIVES OF TYLOSIN
    NARANDJA, A
    SUSKOVIC, B
    KELNERIC, Z
    DJOKIC, S
    JOURNAL OF ANTIBIOTICS, 1994, 47 (05): : 581 - 587
  • [28] Antibacterial activities with the structure-activity relationship of coumarin derivatives
    Qin, Hua-Li
    Zhang, Zai-Wei
    Ravindar, Lekkala
    Rakesh, K. P.
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020, 207
  • [29] STRUCTURE-ACTIVITY RELATIONSHIP OF DAUNORUBICIN AND ITS PEPTIDE DERIVATIVES
    WILSON, DW
    GRIER, D
    REIMER, R
    BAUMAN, JD
    PRESTON, JF
    GABBAY, EJ
    JOURNAL OF MEDICINAL CHEMISTRY, 1976, 19 (03) : 381 - 384
  • [30] Synthesis and structure-activity relationship study of lamellarin derivatives
    Ishibashi, F
    Tanabe, S
    Oda, T
    Iwao, M
    JOURNAL OF NATURAL PRODUCTS, 2002, 65 (04): : 500 - 504